Prosthesis, Hip, Femoral, Resurfacing
Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.
OpenFDA device adverse-event casebook.
FDA Class II (moderate risk, special controls required), regulated under 21 CFR §888.3400 (Orthopedic panel).
FDA MAUDE casebook
openFDA event book Prosthesis, Hip, Femoral, Resurfacing MID-BOOK · MAUDE
#193 of 1000 · 12,333 reports · 1992–2026
- BOOK 12,333 reports
- RANK #193 of 1000
- DEATH 40 death-typed
- INJ 11,997 injury-typed
- MALF 273 malfunction
- SPAN 1992–2026
- PEAK 2013: 2,522
- PHOTO Analyzer
Nearest event-volume peer: Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase (384 report gap)
Prosthesis, Hip, Femoral, Resurfacing sits #193 of 1000 among tracked device types with 12,333 MAUDE reports spanning 1992–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →
Injury-coded reports run above the device-type norm
Prosthesis, Hip, Femoral, Resurfacing carries 97.3% INJURY-coded reports, 67.0pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.
- DEATH 0.3% corpus 1.5% · below corpus mean (-1.2 pp)
- INJ 97.3% corpus 30.3% · above corpus mean (+67.0 pp)
- MALF 2.2% corpus 64.8% · below corpus mean (-62.6 pp)
Lead product-problem code Insufficient Device Problem Information is 55% of coded problems · Lead manufacturer DEPUY INTERNATIONAL LTD. 8010379 accounts for 27% of manufacturer-tagged reports · Top event location is 59% of location-tagged rows .
Prosthesis, Hip, Femoral, Resurfacing in the event-volume neighbourhood
FDA MAUDE report totals among this device type and nearest nationwide peers
- Shoulder Pros…
Shoulder Prosthesis, Reverse Configuration
12,771 reports
- Recorder
Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection)
12,726 reports
- Analyzer
Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase
12,717 reports
- Prosthesis (this)
Prosthesis, Hip, Femoral, Resurfacing
12,333 reports
- Intracranial…
Intracranial Aneurysm Flow Diverter
11,926 reports
- Tampon
Tampon, Menstrual, Unscented
11,865 reports
What this shows Prosthesis, Hip, Femoral, Resurfacing carries 12,333 MAUDE reports, ranked #193 of 1000.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Top Product Problems
Yearly Trend
Reports rose to 15 in 2025, up from an average of 4 in the two years before - a recent-year increase, not a lifetime pattern.
Related Entities for Prosthesis, Hip, Femoral, Resurfacing
Top Manufacturers
Event Locations
Compare DEPUY INTERNATIONAL LTD. 8010379 vs DEPUY INTERNATIONAL →
Nationwide devices with a comparable volume-and-death footprint
Two openFDA-derived peer sets for Prosthesis, Hip, Femoral, Resurfacing: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.
Similar report volume
Nearest other device types by FDA MAUDE report count (12,333 here).
Similar death-typed counts
Nearest other device types by death-typed report count (40 here), distinct from the volume row.
Read our methodology - how this data is sourced, computed, and verified.
Disclaimer: MAUDE figures for Prosthesis, Hip, Femoral, Resurfacing are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.
Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Prosthesis, Hip, Femoral, Resurfacing; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.